Suson, Malyn .

HRN: 27-44-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
AMPICILLIN 1GM (VIAL)
07/09/2025
07/11/2025
IV
2g
Q6
PROM
Checking Initial Appropriateness 
07/10/2025
CEFUROXIME 1.5GM (VIAL)
07/10/2025
07/11/2025
IV
1.5g
Q8
S/p CS
Waiting Final Action 
07/10/2025
CEFUROXIME 500MG (TAB)
07/11/2025
07/18/2025
PO
500mg
BID
S/p CS
Waiting Final Action 
07/10/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/10/2025
07/11/2025
IV
500mg
Q8
S/p CS
Waiting Final Action 
07/10/2025
METRONIDAZOLE 500MG (TAB)
07/11/2025
07/18/2025
PO
500mg
TID
S/p CS
Waiting Final Action 
07/11/2025
MUPIROCIN 2%, 15G (TUBE)
07/11/2025
07/17/2025
TOPICAL
2%
OD
Wound Dressing
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: